Skip to main content

Health

More in Health

Pediatric DiabetesTreatment Trade-offs

FDA Approves First Drug to Delay Type 1 Diabetes Progression in Children

Early Intervention Advocates 40%Clinical Safety Monitors 35%Medical Researchers 25%

6 sources · 22d ago

ExplainerCartilage Regeneration

How Single-Injection Therapies Are Regenerating Cartilage in Aging Joints

Regenerative Medicine Researchers 40%Orthopedic Surgeons 30%Healthcare Economists 30%

3 sources · 23d ago

Supplement SafetyExplainer

Common Joint Supplement Glucosamine Linked to Accelerated Alzheimer's Progression

Medical Researchers 40%Clinical Practitioners 35%Patient Advocates 25%

7 sources · 23d ago

Genetic MedicineTreatment Explainer

FDA Approves First Gene Therapy for Congenital Deafness, Restoring Hearing in Children

Clinical Audiologists & ENTs 45%Deaf Community Advocates 30%Medical Geneticists 25%

6 sources · 23d ago

Food SafetyPolicy Shift

FDA Proposes Rule to End 'Self-Affirmed' Food Safety, Mandating Notification for All New Ingredients

Public Health Advocates 40%Food Industry Counsel 35%Federal Regulators 25%

8 sources · 24d ago

Multiple MyelomaExplainer

U.S. FDA Approves Zenbexus, First-in-Class CELMoD Therapy, for Relapsed Multiple Myeloma

Clinical Oncologists 40%Regulatory & Trial Experts 35%Health Economists 25%

8 sources · 24d ago

Menopause CareExplainer

Estrogen-Only Hormone Therapy Linked to 35% Lower Alzheimer's Pathology Risk

Neurology Researchers 40%Women's Health Advocates 30%Clinical Practitioners 30%

6 sources · 24d ago

Gene TherapyClinical Trial

Single-Dose Gene Therapy Slashes LDL Cholesterol by 62% in Landmark Trial

Clinical Researchers 40%Cardiology Patients 30%Medical Safety Regulators 30%

6 sources · 22d ago

Superbug TrackingPublic Health Alert

CDC Warns Multi-Drug Resistant Candida auris Superbug Cases Exceed 3,400 in 27 States

Public Health Officials 40%Infectious Disease Specialists 35%Healthcare Facility Administrators 25%

3 sources · 24d ago

ExplainerNeuromodulation

Personalized, Accelerated TMS Therapy Achieves Depression Remission in Days, Not Months

Clinical Researchers 40%Patient Access Advocates 35%Health Economists 25%

3 sources · 24d ago

Aging BiologyTrial Watch

Landmark $38M Trial Tests Rapamycin and GLP-1 Drugs to Extend Human Healthspan

Geroscience Researchers 40%Clinical Skeptics 30%Public Health Advocates 30%

7 sources · 25d ago

Multiple MyelomaDrug Approval

FDA Approves First-in-Class Cereblon E3 Ligase Modulator for Multiple Myeloma

Clinical Oncologists 40%Patient Advocacy Groups 35%Regulatory Analysts 25%

8 sources · 13d ago